Section 292 of the Patent Act provides that a person who falsely marks an unpatented article as being patented, where the false patent marking was done with an intent to deceive the public, [s]hall be fined not more than $500 for every such offense. See 35 U.S.C. § 292(a).  The statute permits a qui tam action whereby any private citizen can sue to recover the penalty and retain for itself half of the penalty. Over the last few years, the false marking statute has gained a modicum of popularity as plaintiffs, including in some cases private patent lawyers, have brought false marking claims against defendant patentees who have marked products with expired patent numbers. Indeed, some commentators have described these plaintiffs as a new breed of troll, the marking troll. For a time the incentive to bring false marking claims was held in check by a limiting judicial construction of what constituted an offense for which the penalty could be quantitatively assessed.

Following a hundred year old decision construing the predecessor statute to § 292, London v. Everett H. Dunbar Corp., 179 F. 506, 507-09 (1st Cir. 1910), the majority of district courts addressing the issue of what is an offense under § 292 held that a continuous act of false marking, e.g., marking an entire single production run, counted as only one offense regardless of how many products were improperly marked with a patent number during the continuous act. See e.g., A. G. Design & Associates, LLC v. Trainman Lantern Co., Inc.  Consequently, the financial incentives for a plaintiff to bring a false marking suit were minimal under this construction of offense. That has now changed. The Federal Circuit‘s opinion in Forest Gp., Inc. v. Bon Tool Co., No. 2009-1044, 2009 WL 5064353 (Fed. Cir. Dec. 28, 2009), overrules these district court cases and holds that the penalty of § 292 must be assessed on a per article/product basis with the district court setting the amount of the penalty anywhere from a fraction of a penny to $500 per falsely marked article.

In Forest Group, the patentee sued an accused infringer for patent infringement based on an accused product that was described as being an exact replica of the patentee’s commercial product. The patentee had marked its product with the patent number. During the lawsuit, the accused infringer obtained a summary judgment of noninfringement. After the summary judgment was handed down the patentee commissioned another production run of its commercial product and had the newly made products marked with the patent number. The district court found that the patentee committed false marking for this new production run because it clearly knew the commercial product did not meet the patent claims. While finding a false marking violation, the district court held that there was only one continuous offense, and therefore assessed the total penalty at $500.

On appeal the Federal Circuit vacated the penalty award because the district court erred in ruling there was only one offense of false marking. Applying a de novo review of the district court‘s construction of the statute, the Federal Circuit, in an opinion penned by Judge Moore, held that the text of the statute clearly requires that each article that is falsely marked with intent to deceive constitutes an offense under 35 U.S.C. § 292. Id. at *3 . The court also noted that [u]nder the current statute, district courts have the discretion to assess the per article fine at any amount up to $500 per article. Indeed, the court explicitly instructed that [i]n the case of inexpensive mass- produced articles, a court has the discretion to determine that a fraction of a penny per article is a proper penalty. Id. at * 6. In view of this sliding scale approach to the amount of the penalty, the Federal Circuit noted that district courts have ―the discretion to strike a balance between encouraging enforcement of an important public policy [i.e., ensuring that acts of false marking do not stifle competition or innovation] and imposing disproportionately large penalties for small, inexpensive items produced in large quantities. Id.

In reaching its holding, the Federal Circuit rejected the patentee‘s arguments that the per-article standard should not be adopted because it would encourage a new cottage industry‘ of false marking litigation by plaintiffs who have not suffered any direct harm. Id. at *6.

Some courts have noted that plaintiffs asserting false marking claims must demonstrate an injury-in-fact to the government to have standing to assert a claim. Stauffer v. Brooks Bros., Inc., 2009.  Anyone can Assert Violation (discussing Stauffer and other cases limiting recovery for qui tam suits). If accepted by other courts, this injury-in-fact standard may limit the ability to assert some false marking claims.

Although acknowledging that an amicus brief was filed in th[e] case by an individual who created a holding company to bring qui tam actions in false marking cases, the Federal Circuit noted that [r]ather than discourag[ing] such activities, the false marking statute explicitly permits qui tam actions. Id. The court further justified its per-article standard by noting that [p]enalizing false marking on a per decision basis would not provide sufficient financial motivation for plaintiffs-who would share in the penalty—to bring suit. Id.

Forest Group gives a green light to opportunistic plaintiffs to assert false marking claims when they believe they can show deceptive intent or, more likely, where they believe they can at least articulate a basis to plead a claim that passes muster under Rule 11 and can survive a Rule 12(b)(6) motion to dismiss.

The Federal Circuit has yet to address whether a false marking claim, with its requirement that the false marking be done with the purpose of deceiving the public, should be subject to the heightened pleading requirements of Rule 9(b), in the same way that inequitable conduct, with its requirement to show an intent to deceive the PTO, must meet the Rule 9(b) standards. See Ferguson Beauregard/Logic Controls v. Mega Sys., LLC

The per-article standard may give hope to these plaintiffs of a big payday (albeit one they must share with the federal government) if the defendant has mass produced the alleged falsely marked product. It may also prompt more accused infringers to assert false marking claims as a routine counterclaim to an infringement suit where the patentee markets a product allegedly covered by the asserted patent.

Forest Group makes clear that district courts have discretion in setting the rate of the penalty. However, other than stating that a district court should strike a balance between encouraging enforcement of an important public policy and imposing disproportionately large penalties for small, inexpensive items produced in large quantities, Forest Group does not provide any practical frame work to guide district courts in setting the amount of the penalty. One court may determine that a penalty of one cent per article on one million falsely marked products is proper, while a second court, on the same facts, could find that one dollar is the proper rate, thereby imposing a penalty 100 times larger than the first court. Given the uncertainty in how district courts will set the penalty rate, plaintiffs may feel that they effectively have a chance to spin a false marking roulette wheel and may eagerly do so by filing questionable suits. Plaintiffs may also prey on the uncertainty defendants will face in assessing the possible financial magnitude of a penalty as a means to intimidate or harass defendants into settlements.

In addition to leaving open the question of how to set the per article penalty, the standard in Forest Group fails to address how the penalty should be assessed if the act of false marking does not involve a product that is falsely marked, but only involves an advertisement that falsely identifies the advertised product as being patented. In that scenario should the court assess the penalty on each piece of advertising distributed or broadcasted to the public, on each unmarked product allegedly sold as a result of the improper advertising, on the number of people who saw the advertisement, or some other basis? What happens if the advertising is posted on a website: does the posting count as a single advertisement, or does each click on the webpage count as its own punishable act of false marking? Courts in other legal contexts have followed a single publication rule for such web-based claims. But the single publication rule appears similar to the continuous marking rule the Federal Circuit rejected in Forest Group. These and other questions will surely arise in the near future.

Forest Group does not change the substantive aspects of proving a false marking violation. But it likely changes the financial incentives for bringing false marking claims such that plaintiffs and accused infringers will assert these claims more often in litigation. Accordingly, those who counsel clients on patent matters should become intimately familiar with § 292, and be ready to advise their clients on how to avoid violating § 292 while complying with any duty the clients may have to mark under § 287(a) or having their licensees mark.

Today’s post is by Guest Barista Robert A. Matthews, Jr., Matthews Patent-Law Consulting.and was first published in his Patent Happenings® newsletter.

 

  Print This Post   Email This Post

The Program:

FastTrac® TechVentureTM is a hands-on business development program specifically designed to assist scientists, inventors, engineers and IT developers to commercialize an innovative and scalable technology, product or service.

FastTrac® TechVenture will be presented over a six-week period beginning Tuesday, February 23, 2010.  Each week different business development and management topics will be discussed:

  • Entering and Capturing the Market
  • Financial
  • Entrepreneurship and Building Your Team
  • Protecting Your Intellectual Property
  • Identifying Funding and Working With Investors
  • Cash Management and Operations
  • Professional business coaches and mentors will then work individually with each company to incorporate that topic into the company’s business process.

The Team:

FastTrac® TechVentureTM is sponsored by BIOSTART (an Edison Incubator), Hamiliton County Business Center (an Edison Incubator) and TechSolve (an Edison Center.)

The topic presenters, coaches and mentors are high powered, local business professionals who have launched successful careers and businesses.

The Result:

Upon completion of the entire FastTrac® TechVentureTM program, each participant will have the tools to create a world class enterprise.

The Details:

Dates: 2/23 through 3/30/10
Time: 8:00 am to noon
Location:  Hamilton County Business Center (HCBC)
1776 Mentor Avenue
Conference Room 160
Cincinnati, OH 45212

Cost: $895 per person although 50% of fee will be refunded as a scholarship upon successful completion of the course and submission of a complete business plan.

Visit biostart.org/TechVentureCincy to complete an application

For more information regarding the FastTrac® TechVentureTM program, contact any of the following:

Carol Frankenstein at BIOSTART
cfrankenstein@biostart.org
513.475.6610

Mary Myers at HCBC
mmyers@hcdc.com
513.631.8292

Bruce Vaillencourt at TechSolve
vaillencourt@techsolve.org
513.948.4026

  Print This Post   Email This Post

Eastman’s divestment of its PET business in the EU to Indorama ended up in Delaware federal court as the licensor’s patent infringement action.  Eastman Chemical Company v. AlphaPet Inc. et al. (09-CV-971).  Named as defendants are the Indorama licensees, and affiliates, and a U.S. subsidiary, AlphaPet.

The complaint raises interesting problems about a licensor suing licensees for patent infringement along with a trade secret breach by the licensor’s employees. It underscores the importance of a well thought out forum selection clause that extends to all the licensees and affiliates.

The divestment included a Technology Licensing Agreement, and the transfer of assets and Eastman employees to the licensees. The license limited Indorama to making PET only in its EU facilities. Trade secrets too were licensed, and allegedly, “with a few exceptions” the use was “restricted” to the EU plants. Later, Indorama set up a plant in Alabama, where its subsidiary Alpha Pet operated a “melt-to-resin PET manufacturing process.” The Complaint alleges on “information and belief” that former Eastman employees disclosed trade secrets “relating to the manufacture of PET during the design, start-up and/or operation” of the AlphaPet plant in Alabama. These former employees allegedly knew about the licensed PET technology, as well as other un-licensed IntegRex™ technology for PET.

It is not pleaded whether the allegedly infringed patents were licensed or not, or whether any of the pleaded patents cover the Eastman IntegRex technology.  (Note: Eastman’s IntegRex™ webpage offers “licensing opportunities, patent protection and technical support on a global basis”).

When employees breach an agreement or duty of confidentiality with their employer, the claim against the receiving party, for misuse of the confidential information, can be complicated. In general, notice of the breach, or some other ‘knowing’ misconduct by the recipient, must be proven. The Uniform Trade Secrets Act refers to acquisition by one “who knows or has reason to know that the trade secret was acquired by improper means,” which it defines to include “breach of a duty to maintain secrecy.”

Sure, the employee can be sued, but taking action against the recipient involves proving “improper means.” This can be more difficult when the recipient is a licensee, since a license sometime provides a complete defense. It is part a technical problem – sorting the licensed from the unlicensed technology – and part a problem of proving different elements of distinct business torts.

A further complication arises when an issued patent discloses the alleged trade secrets, or it teaches the essential technology transferred to the licensee. What the patent makes publicly known no longer is a trade secret. Water Tech. v. Calco, 850 F.2d 660 (Fed. Cir. 1988) (“patents issued … before Gartner’s disclosure … so that the information ‘misappropriated’ could not possibly be a trade secret”). Even against a non-licensee, public disclosure can be a complete defense to a trade secret claim. See, Ultimax Cement v. CTS, 587 F.3d 1339, 1354 (Fed. Cir. 12/3/09). Again, sorting out the licensed, from the patented, from the secret technology can be difficult to do, and even harder to explain in a courtroom.

Also, the suit reminds of how important a choice of forum clause can be. The licensed Indorama defendants are in several EU countries, with a U.S. subsidiary in Alabama, and the ultimate parent IRP being a Thailand company.

The parent, IRP, was not a signatory to the license, nor was the U.S. subsidiary AlphaPet. (Alpha Pet has no connection to the 2006 film, Alpha Dog, but it too dealt with a $$$ dispute). IRP is alleged to have “affiliate status” under the terms of the license, and so maybe hooked into the Delaware forum selection clause. By foresight or happenstance, AlphaPet is a Delaware corporation.

Check the last clause you reviewed to see whether it extends to affiliates who get access to the technology from the named licensee.

Today’s post is by Guest Barista Lee Thomason, an IP strategist and former FBT-er who teaches IP law at the UK College of Law.

  Print This Post   Email This Post

Many readers of Patent Baristas may have noticed that the site has been “off-line” for a bit.  With my deepest apologies, I have found myself in the midst of a family emergency that is requiring most of my time and leaving little or no time for extras like blogging.  Since the difficulties may be extended for the next several months, I wanted to write to ask if anyone has an interest in writing guest posts for submission to Patent Baristas.

We know there are lots of great folks out there with even more knowledge on patents and intellectual property. We’ll make it easy for you to submit blog posts to us – all you have to do is send us your articles and we’ll post it for you. We’d also seek biographical information about yourself.  This will give us the chance to show our readers where you’re coming from in your experiences and credentials.  Feel free to offer a single submission, weekly or even daily.

If you are an author, editor, publisher, or agent, and would like to guest blog with us, please email us your request at baristas@patentbaristas.com.  If you have preferred dates or time-frames, please include those in your request so we can begin coordinating the schedule.  The only requirements are that it be well written, on-topic, and non-defamatory.  A series of posts on a concentrated subject matter would also be a tremendous asset.

[On a side note, I would like to say a special thanks to those readers -- generally fellow bloggers --who noticed my absence and took the time to write a kind note.  I appreciate your care and concern.  ~Stephen]

  Print This Post   Email This Post

Though even thinking on the subject of time may prove discomforting, it is not a bad idea—especially at the beginning of a new year.

As we look into 2010 we look at a block of time. We see 12 months, 52 weeks, 365 days, 8,760 hours, 525,600 minutes, 31,536,000 seconds. And all is a gift from God. We have done nothing to deserve it, earn it, or purchased it. Like the air we breathe, time comes to us as a part of life.

The gift of time is not ours alone. It is given equally to each person. Rich and poor, educated and ignorant, strong and weak—every man, woman and child has the same twenty-four hours every day.

Another important thing about time is that you cannot stop it. There is no way to slow it down, turn it off, or adjust it. Time marches on.

And you cannot bring back time. Once it is gone, it is gone. Yesterday is lost forever. If yesterday is lost, tomorrow is uncertain. We may look ahead at a full year’s block of time, but we really have no guarantee that we will experience any of it.

Obviously, time is one of our most precious possessions. We can waste it. We can worry over it. We can spend it on ourselves.  Or, as good stewards, we can invest it in the kingdom of God.

The new year is full of time. Will you make every minute count?

~Steven B. Cloud, Pulpit Helps, Vol. 14, # 2

  Print This Post   Email This Post

The U.S. Patent Office has learned of a new technological advance called “rss feed” and has instituted the system for the USPTO Systems Status and Availability site a mere 10 years after Netscape started using it.

On the Electronic Business Center, you can check the web page for the latest information on operating status and availability of Online Business Systems.  However, subscribing to the available feeds will be much easier and more immediate.

For Standard Hours of Availability for Online Business Systems, System Descriptions, and Operating Requirements/Compatibilities, see the links here:

Also, don’t forget the Director’s Forum: David Kappos’ Public Blog.  [No word on David Kappos' Secret Blog] The site, ostensibly by Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos, features fairly frequent updates of the goings-on at the Patent Office.  This blog, while it can’t be completely open, is a good way for the public to dialog on patent issues.

In a post on the Supreme Court’s April 2007 decision in KSR v. Teleflex regarding obviousness, Kappos details how the Office’s first step toward addressing the implications of the KSR decision was to publish examination guidelines – available at http://www.uspto.gov/web/offices/com/sol/notices/72fr57526.pdf – for its personnel to follow when determining obviousness. In accordance with the Supreme Court’s instructions regarding flexibility, the guidelines recognized that an examiner’s approach to obviousness had been broadened beyond the strict teaching-suggestion-motivation test. At the same time, they also stressed that in order to arrive at a proper conclusion of obviousness, examiners still needed to couple sound reasoning with particular findings of fact.

Some have suggested that the Office is determining obviousness in a way that stifles innovation by refusing patents for truly inventive subject matter. Practitioners asked the PTO to provide examples of non-obvious claims in view of KSR to serve as a complement to the examples of obvious claims already in the guidelines.  He indicated that now that a body of case law has been decided in light of the KSR decision, they are able to undertake that task.

  Print This Post   Email This Post

GOClogoJenn_200_200The FDA and Xavier University have co-developed the first annual Global Outsourcing Conference to be held June 13-16, 2010.

GOC 2010, which is billed as “being designed collaboratively by FDA, Innovator Companies, and Contract Organizations to address Global Outsourcing challenges that reside on all sides,” focuses on four key discussions:

  • Global Compliance
  • The “Business” of Quality
  • Supply Chain Control
  • Contract Relationships

Few conferences achieve the level of open dialogue and sharing of ideas amongst participants that the Global Outsourcing Conference will master. An engaging conference is more challenging to host, more difficult to facilitate, but the most rewarding for everyone involved. The topics will be controversial, but the atmosphere will be one of collaboration. We will work together – from all sides of the issues.

Through careful planning and masterful facilitation, you will be engaged with colleagues “from the other side” and will enjoy the interactions that lead to relationships lasting the rest of your careers.

Who Should Attend:

The Conference will benefit companies of all sizes and employees at all levels including:

  • Employees at all levels of the organization – the solutions are not exclusive, and neither is this conference
  • Innovator Company representatives
  • Contract Organization representatives
  • Consultants
  • Government Officials
  • Quality Operations
  • Supply Chain
  • Procurement
  • Regulatory Affairs

Note: Continuing Education Units offered for Industry and Government personnel.  Details here for more information.

  Print This Post   Email This Post

Blawg100The ABA Journal has released third annual Blawg 100 – the best legal blogs as selected by the Journal’s editors.  This year’s list includes 40 blawgs that are new to the list.

In general, I’m uncomfortable in trying to put blogs into any kind of subjective ranking since many are narrowly tailored and have different priorities and audiences.  There’s even the question of what is the definition of a blawg, such as, should the The Am Law Daily by American Lawyer reporters be called a  blawg or a commercial news site?

Even then, it’s quite subjective as what category to place a blawg.  In the Journal’s rankings, just 16 blawgs are in the Practice Specific category.    Paul Caron’s TaxProf Blog is under the Legal Theory and not the Practice Specific category [Disclaimer: Paul lives directly across the street from me.]

Intellectual property law is heavily dominated by tech geeks so there are just flat out a lot of great blogs in the practice area (witness Gene Quinn’s earlier rankings).  Among IP listings, Dennis Crouch at Patently-O and Gene Quinn at IP Watchdog were recognized in the Practice Specific category.

Again this year, you can go vote for your favorite in each of the 10 categories.  They’ll be counting votes from Dec. 1st through Dec. 31st.

Having a short attention span, my personal favorites change weekly, if not daily, depending on my immediate mood and interests.  Blogs I’m currently following closely include:

Of course, I also follow The Secret Diary of Steve Jobs and PhotoshopDisasters so you may not want to take advice from me.

Anyway, the winners of the Blawg 100 will be announced in the February edition of the Journal.

  Print This Post   Email This Post